GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,405 | -16.1% | 4,842 | +0.7% | 0.00% | – |
| Q2 2023 | $286,387 | -40.1% | 4,810 | -43.1% | 0.00% | -100.0% |
| Q1 2023 | $478,495 | -43.9% | 8,448 | -26.5% | 0.00% | -50.0% |
| Q4 2022 | $853,659 | +42.0% | 11,494 | +14.1% | 0.00% | +100.0% |
| Q3 2022 | $601,000 | +4.2% | 10,076 | -1.9% | 0.00% | 0.0% |
| Q2 2022 | $577,000 | -5.7% | 10,266 | +23.8% | 0.00% | 0.0% |
| Q1 2022 | $612,000 | +3.6% | 8,295 | +1.3% | 0.00% | 0.0% |
| Q4 2021 | $591,000 | -3.3% | 8,192 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $611,000 | +0.3% | 7,985 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $609,000 | +17.3% | 7,869 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $519,000 | +3.2% | 8,422 | +9.0% | 0.00% | 0.0% |
| Q4 2020 | $503,000 | +14.8% | 7,728 | -12.6% | 0.00% | 0.0% |
| Q3 2020 | $438,000 | -0.2% | 8,847 | -4.0% | 0.00% | 0.0% |
| Q2 2020 | $439,000 | +14.9% | 9,211 | +2.5% | 0.00% | 0.0% |
| Q1 2020 | $382,000 | -16.4% | 8,982 | +15.7% | 0.00% | 0.0% |
| Q4 2019 | $457,000 | +10.7% | 7,760 | -4.0% | 0.00% | 0.0% |
| Q3 2019 | $413,000 | +103.4% | 8,083 | +68.3% | 0.00% | 0.0% |
| Q2 2019 | $203,000 | -43.9% | 4,803 | -34.5% | 0.00% | 0.0% |
| Q1 2019 | $362,000 | +2.8% | 7,331 | -9.9% | 0.00% | 0.0% |
| Q4 2018 | $352,000 | -40.2% | 8,141 | -21.6% | 0.00% | -50.0% |
| Q3 2018 | $589,000 | +7.7% | 10,379 | -4.3% | 0.00% | 0.0% |
| Q2 2018 | $547,000 | -12.8% | 10,851 | -13.9% | 0.00% | 0.0% |
| Q1 2018 | $627,000 | -47.6% | 12,607 | -56.7% | 0.00% | -50.0% |
| Q4 2017 | $1,197,000 | +3.4% | 29,121 | -25.3% | 0.00% | 0.0% |
| Q3 2017 | $1,158,000 | -9.0% | 38,971 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $1,273,000 | +2.4% | 38,384 | -8.5% | 0.00% | 0.0% |
| Q1 2017 | $1,243,000 | +49.2% | 41,935 | +24.8% | 0.00% | +33.3% |
| Q4 2016 | $833,000 | -6.1% | 33,595 | -14.5% | 0.00% | 0.0% |
| Q3 2016 | $887,000 | -11.7% | 39,311 | -6.8% | 0.00% | -25.0% |
| Q2 2016 | $1,005,000 | +3.5% | 42,175 | +3.2% | 0.00% | 0.0% |
| Q1 2016 | $971,000 | -18.9% | 40,871 | -5.1% | 0.00% | -20.0% |
| Q4 2015 | $1,198,000 | +82.1% | 43,073 | +35.2% | 0.01% | +66.7% |
| Q3 2015 | $658,000 | +54.5% | 31,862 | +91.8% | 0.00% | +50.0% |
| Q2 2015 | $426,000 | +200.0% | 16,614 | +196.2% | 0.00% | +100.0% |
| Q1 2015 | $142,000 | +14.5% | 5,609 | +8.2% | 0.00% | – |
| Q4 2014 | $124,000 | +8.8% | 5,182 | -10.7% | 0.00% | – |
| Q3 2014 | $114,000 | -32.9% | 5,805 | -18.7% | 0.00% | -100.0% |
| Q2 2014 | $170,000 | -15.8% | 7,136 | -6.4% | 0.00% | 0.0% |
| Q1 2014 | $202,000 | +87.0% | 7,620 | +42.6% | 0.00% | – |
| Q4 2013 | $108,000 | +260.0% | 5,342 | +208.8% | 0.00% | – |
| Q3 2013 | $30,000 | +15.4% | 1,730 | +10.9% | 0.00% | – |
| Q2 2013 | $26,000 | – | 1,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |